Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples